Anavex Life Sciences Corp (AVXL)

[jimmy667]

The question regarding OTC is light years off base and speeding like a runaway train in the wrong direction on the wrong track. Anavex is not an OTC penny stock it is a fully reporting Nasdq Company in full compliance with all Nasdq regulations and has been each and every day since uplifting to NASDQ IN Oct 2015. It has never had even one deficient issuer notice.
The question is rather than lumping AVXL in with the Universe of OTC stocks what percentage of Companies that successfully uplifted to NASDQ went on to be successful? One might see that this lie of statistics that all OTC stocks fail is that all of the successful Companies the started in the OTC matured into fully reporting Companies and uplifted to fully reporting exchange like NASDQ NYSE AMEX and the ones that didn't failed. Not because they started on the OTC but exactly because they failed before reaching fully reporting status.
Anavex had poor management before Missling arrived in 2013-2014 and he quickly moved the Company forward to the point of uplifting to NASDQ in the October surprise of 2015. Now Avavex is advancing simultaneously on three fronts winning every battle fought the Company has fought. Gaining the objective on two of the three fronts will ensure complete victory gaining the objective on even just one front will allow Anavex the put more resources into the other two fronts and open up new fronts and gain powerful Allies on all fronts.
Anavex is battling the root causes or cascades of reactions of CNS malfunctions not symptomatic relief. Therefore it takes longer than the quick strikes that attack the more troublesome symptoms. The penultimate objective is to shift the paradigm of treating symptoms to solving the underlying malfunctions on a cellular and organelles level. To this endeavour Anavex is employing the greatest ally medical science will ever have, the Human Body Itself more specifically by concommitally modulating the SR1 and M1 receptors at the cellular organelles level.
If this effort is successful Anavex could possibly occupy nearly the entire CNS field as Gilead once did with anti-viral drugs.
When I first invested in GILD everyone said no cure for HIV or other Viral all attempts have failed. Sarcastically "Cure for HIV yea right haha they will fail" and the share price of GILD lanuashed for years. Sound familiar?